BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 32004514)

  • 1. Cannabinoids in the descending pain modulatory circuit: Role in inflammation.
    Bouchet CA; Ingram SL
    Pharmacol Ther; 2020 May; 209():107495. PubMed ID: 32004514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoids and Opioids Differentially Target Extrinsic and Intrinsic GABAergic Inputs onto the Periaqueductal Grey Descending Pathway.
    Winters BL; Lau BK; Vaughan CW
    J Neurosci; 2022 Oct; 42(41):7744-7756. PubMed ID: 36414010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous opioid peptides in the descending pain modulatory circuit.
    Bagley EE; Ingram SL
    Neuropharmacology; 2020 Aug; 173():108131. PubMed ID: 32422213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action.
    Maione S; Piscitelli F; Gatta L; Vita D; De Petrocellis L; Palazzo E; de Novellis V; Di Marzo V
    Br J Pharmacol; 2011 Feb; 162(3):584-96. PubMed ID: 20942863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex-specific cannabinoid 1 receptors on GABAergic neurons in the ventrolateral periaqueductal gray mediate analgesia in mice.
    Jiang Z; Wang Q; Zhao J; Wang J; Li Y; Dai W; Zhang X; Fang Z; Hou W; Xiong L
    J Comp Neurol; 2022 Sep; 530(13):2315-2334. PubMed ID: 35716006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compensatory Activation of Cannabinoid CB2 Receptor Inhibition of GABA Release in the Rostral Ventromedial Medulla in Inflammatory Pain.
    Li MH; Suchland KL; Ingram SL
    J Neurosci; 2017 Jan; 37(3):626-636. PubMed ID: 28100744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulatory effects of cannabinoids on brain neurotransmission.
    Cohen K; Weizman A; Weinstein A
    Eur J Neurosci; 2019 Aug; 50(3):2322-2345. PubMed ID: 30882962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid disruption of learning mechanisms involved in reward processing.
    Lupica CR; Hoffman AF
    Learn Mem; 2018 Sep; 25(9):435-445. PubMed ID: 30115765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinociception and modulation of rostral ventromedial medulla neuronal activity by local microinfusion of a cannabinoid receptor agonist.
    Meng ID; Johansen JP
    Neuroscience; 2004; 124(3):685-93. PubMed ID: 14980738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of fatty-acid amide hydrolase enhances cannabinoid stress-induced analgesia: sites of action in the dorsolateral periaqueductal gray and rostral ventromedial medulla.
    Suplita RL; Farthing JN; Gutierrez T; Hohmann AG
    Neuropharmacology; 2005 Dec; 49(8):1201-9. PubMed ID: 16129456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of descending serotonergic and noradrenergic pathways in CB1 receptor-mediated antinociception.
    Dogrul A; Seyrek M; Yalcin B; Ulugol A
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Jul; 38(1):97-105. PubMed ID: 22300745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid Receptor Type 1 and Its Role as an Analgesic: An Opioid Alternative?
    Milligan AL; Szabo-Pardi TA; Burton MD
    J Dual Diagn; 2020; 16(1):106-119. PubMed ID: 31596190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro.
    Vaughan CW; Connor M; Bagley EE; Christie MJ
    Mol Pharmacol; 2000 Feb; 57(2):288-95. PubMed ID: 10648638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy.
    Rice AS; Farquhar-Smith WP; Nagy I
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):243-56. PubMed ID: 12052040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetaminophen Relieves Inflammatory Pain through CB
    Klinger-Gratz PP; Ralvenius WT; Neumann E; Kato A; Nyilas R; Lele Z; Katona I; Zeilhofer HU
    J Neurosci; 2018 Jan; 38(2):322-334. PubMed ID: 29167401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioids and cannabinoids interactions: involvement in pain management.
    Desroches J; Beaulieu P
    Curr Drug Targets; 2010 Apr; 11(4):462-73. PubMed ID: 20017728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoids in pain and inflammation.
    Mbvundula EC; Rainsford KD; Bunning RA
    Inflammopharmacology; 2004; 12(2):99-114. PubMed ID: 15265314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid-sparing effects of cannabinoids on morphine analgesia: participation of CB
    Chen X; Cowan A; Inan S; Geller EB; Meissler JJ; Rawls SM; Tallarida RJ; Tallarida CS; Watson MN; Adler MW; Eisenstein TK
    Br J Pharmacol; 2019 Sep; 176(17):3378-3389. PubMed ID: 31218677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mode of action of cannabinoids on nociceptive nerve endings.
    Kress M; Kuner R
    Exp Brain Res; 2009 Jun; 196(1):79-88. PubMed ID: 19306092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular and circuit diversity determines the impact of endogenous opioids in the descending pain modulatory pathway.
    McPherson KB; Ingram SL
    Front Syst Neurosci; 2022; 16():963812. PubMed ID: 36045708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.